International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; 5 of the 68 sources its claims cite were checked for support.
Abstract
In the accompanying comment letter (1), Weinert summarizes published data from the Brazilian Gestational Diabetes Study (2) and comments on applying International Association of Diabetes and Pregnancy Study Groups (IADPSG) Consensus Panel recommendations (3) for the diagnosis of gestational diabetes mellitus (GDM) to that cohort. The Brazilian study provided evidence that adverse perinatal outcomes are associated with levels of maternal glycemia below those diagnostic of GDM by American Diabetes Association or World Health Organization criteria. However, the results were potentially confounded by the treatment of GDM. It did find that women with GDM were at increased risk for some …
Overview
CoChat Summary
## TL;DR
This IADPSG consensus report recommends new gestational diabetes mellitus (GDM) diagnostic thresholds based on HAPO study data, using a 75-g OGTT and outcome-linked glucose cutoffs. It also recommends early detection of overt diabetes in pregnancy and notes that these recommendations will increase the frequency of diagnosed hyperglycemic disorders in pregnancy.
## Key findings
- In the HAPO study, a 75-g OGTT was performed in a heterogeneous, multinational, multicultural, ethnically diverse cohort of approximately 25,000 women in the third trimester; medical caregivers were blinded unless predefined glucose criteria were exceeded.
- The report states that the HAPO data showed continuous, graded associations between maternal glucose and primary outcomes, with no obvious thresholds; associations were also observed for secondary outcomes and did not differ among centers.
- The recommended diagnostic thresholds correspond to glucose levels where odds for birth weight >90th percentile, cord C-peptide >90th percentile, and percent body fat >90th percentile reached 1.75 times the estimated odds at mean glucose values; by these criteria, FPG alone identified 8.3% of the HAPO cohort, FPG plus 1-hour glucose identified an additional 5.7%, and 2-hour glucose another 2.1%, for a total GDM incidence of 17.8%.
- Among the HAPO cohort, 11.1% had only one elevated result, 3.9% had two elevated results, 1.1% had all three elevated, and 1.7% were unblinded because FPG or 2-hour glucose exceeded 5.8 mmol/l (105 mg/dl) or 11.1 mmol/l (200 mg/dl).
## Methods
- Consensus report based on review of the HAPO study, additional unpublished HAPO findings, and other published studies discussed at a June 2008 IADPSG workshop/meeting in Pasadena, followed by consensus panel deliberation.
- HAPO design described as observational: a 75-g OGTT in a large multinational cohort, with blinded caregivers except for preset safety thresholds.
- Thresholds were derived from fully adjusted logistic regression models relating continuous maternal glucose measures (FPG, 1-hour, 2-hour) to outcomes; the panel selected an odds ratio threshold of 1.75 relative to mean glucose values.
## Limitations
- The paper states that recommendations for detecting overt diabetes during pregnancy are based on the opinions of the IADPSG Consensus Panel because prospective studies or appropriately designed clinical trials were not available.
- It states that it was not determined whether universal early testing for overt diabetes is clinically valuable or cost-effective.
- Evident from the text: the HAPO study was observational, not a clinical trial, so the diagnostic thresholds are inferred from associations rather than randomized intervention effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Valid · 0 Not valid · 36 Not checked · 22 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Similar associations were also observed for secondary outcomes (25,26).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
The Abstract of our copy states that the predefined primary outcomes (size at birth, cesarean delivery, neonatal hypoglycemia, fetal hyperinsulinemia) were reported elsewhere, and that this report's goals were to examine maternal glycemia against additional/newborn anthropometric outcomes (sum of skin folds, individual skin folds, percent body fat) plus cord C-peptide. The Results report strong, graded, continuous associations for these outcomes (e.g., ORs 1.33–1.47 for percent body fat >90th percentile and 1.28–1.56 for individual skin folds), and the Discussion explicitly says 'This pattern is similar to that reported for maternal glucose and birth weight >90th percentile.' That covers the claim's substance — similar associations for the secondary/additional outcomes — even though the paper does not use the label 'secondary outcomes'. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Associations of LGA and excess adiposity with fetal hyperinsulinemia are strong and independent of confounders (26,37,38).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
What the sources say
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
In the Results (Table 5), higher cord C-peptide, the paper’s measure of fetal insulin, is strongly associated with birth weight above the 90th percentile and adiposity measures. The Discussion states that the relationships persisted after adjustment for potential confounders. The paper does not claim that every possible confounder was excluded. (LLM, conf=0.92)
- Not checked yetcites [37] Metzger BE Silverman BL Freinkel N Dooley SL Ogata ES Green OC: Amniotic fluid insulin concentration as a predictor of obesity. Arch Dis Child 1990; 65: 1050– 1052 2241225 PMC1590256 source
- Not checked yetcites [38] Weiss PA Haeusler M Tamussino K Haas J: Can glucose tolerance test predict fetal hyperinsulinism? BJOG 2000; 107: 1480– 1485 11192103 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Although not directly comparable, it was concluded that results of the two randomized controlled trials (47,48) and HAPO (25,26) are highly complementary.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM > Other considerations
What the sources say
- Supportedcites [47] Crowther CA Hiller JE Moss JR McPhee AJ Jeffries WS Robinson JS: Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477– 2486 15951574 source
The paper identifies itself as a randomized clinical trial and reports its treatment results (secondary outcomes; page unavailable). In the citing sentence, this citation identifies one of the two trials whose results are being discussed; it does not attribute the cross-study judgment of complementarity to this trial paper. (LLM, conf=0.88)
- Not checked yetcites [48] Landon MB Spong CY Thom E Carpenter MW Ramin SM Casey B Wapner RJ Varner MW Rouse DJ Thorp JM Jr Sciscione A Catalano P Harper M Saade G Lain KY Sorokin Y Peaceman AM Tolosa JE Anderson GB: Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009: 361; 1339– 1348. PMC2804874 19797280
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Could not verifycites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 sourceExperimental — accuracy not yet measured
The Abstract reports HAPO findings on maternal glucose and pregnancy outcomes, but does not compare them with randomized trials. Searches for randomized trials and for the claimed complementarity found no passage in our copy making that comparison. No page numbers were available. (LLM, conf=0.70)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
In the paper
“Importantly, there were continuous graded relationships between higher maternal glucose and increasing frequency of the primary outcomes, independent of other risk factors (25).”
- Also stated in: § Future considerations · boosted
“The HAPO study was a basic epidemiological investigation that for the first time conclusively identified strong continuous associations of maternal glucose levels below those diagnostic of diabetes with several perinatal outcomes.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Future considerations · boosted
None of the sources cited for this claim have been checked yet.
In the paper
“HAPO data show strong linear associations of risks for >90th percentiles of birth weight, cord C-peptide, and percent body fat with each of three measures of maternal glucose (FPG, 1-h, and 2-h post–75-g load).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
40 more claims
Create a free account to see all 62 claims and to verify the 63 references still open.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GDM was identified when fasting blood glucose (FBG) ≥ 5.1 mmol/L during the first trimester or any plasma glucose after a 75 g OGTT performed as: FBG ≥ 5.1 mmol/L, 1 h after glucose load ≥ 10.0 mmol/L or 2 h after glucose load ≥ 8.5 mmol/L using the criteria of International Association of Diabetes and Pregnancy Study Groups (IADPSG) [28].”
From Associations of maternal pre-pregnancy BMI and gestational weight gain with the risks of adverse pregnancy outcomes in Chinese women with gestational diabetes mellitus (2023) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“to adopt diagnostic glucose thresholds corresponding to a HAPO OR of 1.75 (fasting plasma glucose [FPG] 5.1–6.9 mmol/L, one‐hour plasma glucose [1hPG] ≥ 10.0 mmol/L, and/or two‐hour plasma glucose [2hPG] 8.5–11.0 mmol/L). 14”
From Australasian Diabetes in Pregnancy Society ( ADIPS ) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes (2025) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The IADPSG diagnostic thresholds are the first criteria based on risks of adverse perinatal outcomes, rather than risk of subsequent development of maternal diabetes1 or by applying thresholds that define impaired glucose tolerance outside of pregnancy.5,6”
From Gestational Diabetes Mellitus (2019) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“following the diagnostic criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) (18)”
From Diabetes gestacional y riesgo de apnea obstructiva del sueño en el tercer trimestre (2025) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Based on the HAPO Study and other studies, new criteria for the diagnosis of gestational diabetes were proposed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) 2 and adopted by the World Health Organization and others.3,4”
From Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity (2018) · cites this paper as [2]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303 · cited 2×
“Long-term risks associated with fetal macrosomia in infants of women with GDM (independent of confounders) include childhood overweight (43,44) and metabolic factors that may increase risk of cardiovascular disease (CVD) (45).”
BackgroundA Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817
(1964) · PubMed · Cited by 1,230
Research works printed but not linked: 2
- Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Health Canada 1994; 15– 23
- National Collaborating Centre for Women's and Children's Health. Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London, U.K., RCOG Press, 2008 21370515
Cited by
Items 801–900 of 1,132
Lawlor, D. A., West, J., Fairley, L., Nelson, S. M., Bhopal, R. S., Tuffnell, D. J., Freeman, D. J., Wright, J., Whitelaw, D. C., & Sattar, N. A. (2014) · Diabetologia · doi:10.1007/s00125-014-3386-6 · Cited by 52
Diagnosing gestational diabetes: can expert opinions replace scientific evidence?
Long, H. (2011) · Diabetologia · doi:10.1007/s00125-011-2228-z · Cited by 56
“In March 2010, a consensus panel from the International Association of Diabetes and Pregnancy Study Groups (IADPSG) published new recommendations for the diagnosis of GDM [4].”
Leng, J., Liu, G., Zhang, C., Xin, S., Chen, F., Li, B., Tian, H., Yu, Z., Tuomilehto, J., Hu, G., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1103 · Cited by 48
Goyal, S., Rani, J., Bhat, M. A., & Vanita, V. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i6.656 · Cited by 55
Zhang, Z., Zhou, Z., & Li, H. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14119 · Cited by 50
“A standard test for GDM diagnosis is the 75 g 2 h oral glucose tolerance test (OGTT) performed at 24 – 28 weeks of gestation, as recommended by the International Association of Diabetes and Pregnancy Study Groups 8 .”
BackgroundMethodPrevention of gestational diabetes mellitus: Where are we now?
Simmons, D. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12495 · Cited by 48
Chen, D., Zhang, A., Fang, M., Fang, R., Ge, J.-M., Jiang, Y., Zhang, H., Han, C., Ye, X., Huang, H., et al. (2014) · BMC Medical Genetics · doi:10.1186/s12881-014-0108-3 · Cited by 56
“GDM was diagnosed according to the criteria recommended by International Association of Diabetes and Pregnancy Study Groups (IADPSG) [35].”
MethodZuhur, S. S., Erol, R. S., Kuzu, İ., & Altuntaş, Y. (2013) · Clinics · doi:10.6061/clinics/2013(05)13 · Cited by 48
Liao, S., Mei, J., Song, W., Liu, Y., Tan, Y. ‐., Chi, S., Li, P., Chen, X., & Deng, S. (2014) · Diabetic Medicine · doi:10.1111/dme.12349 · Cited by 48
First trimester gestational diabetes screening – Change in incidence and pharmacotherapy need
Alunni, M., Roeder, H., Moore, T. R., & Ramos, G. A. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.04.027 · Cited by 48
“[4] Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al.”
BackgroundYe, M., Liu, Y., Cao, X., Yao, F., Liu, B., Li, Y., Wang, Z., & Xiao, H. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.02.007 · Cited by 56
“And the diagnosis of GDM was made according to IADPSG (The International Association of Diabetes and Pregnancy Study Groups) criteria [13].”
BackgroundMethodInfluentialPhysical Activity Patterns in Normal-Weight and Overweight/Obese Pregnant Women
Bacchi, E., Bonin, C., Zanolin, M. E., Zambotti, F., Livornese, D., Donà, S., Tosi, F., Baldisser, G., Ihnatava, T., Sarra, D. D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166254 · Cited by 55
MTNR1A and MTNR1B gene polymorphisms in women with gestational diabetes
Tarnowski, M., Malinowski, D., Safranow, K., Dziedziejko, V., & Pawlik, A. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1276556 · Cited by 48
Chatzakis, C., Goulis, D. G., Mareti, E., Eleftheriades, M., Zavlanos, A., Dinas, K., & Sotiriadis, A. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107924 · Cited by 45
Zhang, Y., Lan, X., Cai, C., Li, R., Gao, Y., Yang, L., Wu, C., Dong, H., Pang, X., Bai, D., et al. (2019) · American Journal of Perinatology · doi:10.1055/s-0039-3402724 · Cited by 48
Crusell, M. K. W., Hansen, T. H., Nielsen, T., Allin, K. H., Rühlemann, M. C., Damm, P., Vestergaard, H., Rørbye, C., Jørgensen, N. R., Christiansen, O. B., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.536282 · Cited by 54
Mild Gestational Diabetes and Adverse Pregnancy Outcome: A Systemic Review and Meta-Analysis
Yarandi, R. B., Vaismoradi, M., Panahi, M. H., Kymre, I. G., & Behboudi‐Gandevani, S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.699412 · Cited by 57
Vinter, C. A., Jørgensen, J. S., Ovesen, P., Beck‐Nielsen, H., Skytthe, A., & Jensen, D. M. (2014) · Diabetic Medicine · doi:10.1111/dme.12548 · Cited by 47
Stability of glucose in plasma with different anticoagulants
Fobker, M. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-1049 · Cited by 47
Sweeting, A. N., Ross, G. P., Hyett, J., Molyneaux, L., Tan, K., Constantino, M., Harding, A. J., & Wong, J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2951 · Cited by 47
Effects of a modestly lower carbohydrate diet in gestational diabetes: a randomized controlled trial
Mijatovic, J., Louie, J. C. Y., Buso, M. E., Atkinson, F. S., Ross, G. P., Markovic, T. P., & Brand-Miller, J. C. (2020) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa137 · Cited by 47
A Multi-State Analysis of Early-Term Delivery Trends and the Association With Term Stillbirth
Little, S. E., Zera, C., Clapp, M. A., Wilkins-Haug, L. E., & Robinson, J. N. (2015) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001109 · Cited by 47
Refining the diagnosis of gestational diabetes mellitus: a systematic review and meta-analysis
Francis, E. C., Powe, C. E., Lowe, W. L., White, S. L., Scholtens, D. M., Yang, J., Zhu, Y., Zhang, C., Hivert, M.-F., Kwak, S. H., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00393-8 · Cited by 34
“Subgroup analysis, where we strati fi ed studies by enrollment during or after 2010 (all of which used IADPSG diagnostic criteria), or study quality rating, or restricted to studies with covariate adjustment did not produce substantially different results (Supplementary Table 2).”
InfluentialObjectively recorded physical activity and the association with gestational diabetes
Mørkrid, K., Jenum, A. K., Berntsen, S., Sletner, L., Richardsen, K. R., Vangen, S., Holme, I., & Birkeland, K. I. (2014) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/sms.12183 · Cited by 44
Huhn, E. A., Massaro, N., Streckeisen, S., Manegold-Brauer, G., Schoetzau, A., Schulzke, S. M., Winzeler, B., Hoesli, I., & Lapaire, O. (2017) · Journal of Perinatal Medicine · doi:10.1515/jpm-2016-0099 · Cited by 47
Franzago, M., Fraticelli, F., Nicolucci, A., Celentano, C., Liberati, M., Stuppia, L., & Vitacolonna, E. (2017) · Journal of Diabetes Research · doi:10.1155/2017/4612623 · Cited by 50
Effect of maternal obesity on birthweight and neonatal fat mass: A prospective clinical trial
Mitanchez, D., Jacqueminet, S., Nizard, J., Tanguy, M., Ciangura, C., Lacorte, J., Carné, C. D., Foix-L'Hélias, L., Chavatte‐Palmer, P., Charles, M.-A. A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181307 · Cited by 51
Chaparro, A. P., Realini, O., Hernández, M., Albers, D., Weber, L., Ramírez, V., Param, F., Kusanovic, J. P., Sorsa, T. A., Rice, G. E., et al. (2020) · Journal of Periodontology · doi:10.1002/jper.19-0743 · Cited by 55
Nogues, P., Santos, E. D., Couturier‐Tarrade, A., Berveiller, P., Arnould, L., Lamy, E., Grassin‐Delyle, S., Vialard, F., & Dieudonné, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa660 · Cited by 51
Kent, N. L., Young, S. L., Akison, L. K., & Cuffe, J. S. M. (2021) · Endocrine · doi:10.1007/s12020-021-02733-x · Cited by 47
Laafira, A., White, S. W., Griffin, C. J., & Graham, D. (2016) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12394 · Cited by 46
Liang, X., Fu, Y., Lu, S., Shuai, M., Miao, Z., Gou, W., Shen, L., Liang, Y., Xu, F., Tian, Y., et al. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2023.100823 · Cited by 72
Risk stratification in early pregnancy for women at increased risk of gestational diabetes
Harrison, C. L., Lombard, C. B., East, C. E., Boyle, J. A., & Teede, H. J. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.09.006 · Cited by 50
“Women that did not complete an 158 OGTT at 28 weeks gestation were excluded from data analysis relating to IADPSG, as per the 159 recommended one-step screening approach [21].”
MethodWomen with diabetes in pregnancy: different perceptions and expectations
Lawrence, J. M. (2010) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2010.10.003 · Cited by 58
Zhang, C., Li, Y., Wang, L., Sun, S., Liu, G., Leng, J., Guo, J., Lv, L., Li, W., Zhang, C., et al. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2650 · Cited by 55
Riyadh Mother and Baby Multicenter Cohort Study: The Cohort Profile
Wahabi, H., Fayed, A. A., Esmaeil, S. A., Alzeidan, R. A., Elawad, M., Tabassum, R., Hansoti, S., Magzoup, M. E., Al-Kadri, H. M., Elsherif, E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150297 · Cited by 57
Pastakia, S. D., Njuguna, B., Onyango, B. A., Washington, S., Christoffersen-Deb, A., Kosgei, W. K., & Saravanan, P. (2017) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-017-1415-4 · Cited by 44
“Diabetes and Pregnancy Study Group (IADPSG) in 2013 for the diagnosis of GDM [9, 10].”
BackgroundSudasinghe, S. P. B. H., Wijeyaratne, C. N., & Ginige, P. S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.013 · Cited by 48
Krstevska, S. S., Bogoev, M. K., Bogoeva, K., Zisovska, E., Samardziski, I., Nakova, V. V., Livrinova, V., Todorovska, I., Sima, A., & Blazevska-Siljanoska, V. (2018) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2018.200 · Cited by 49
Yang, M., Fan, X., Wu, J., & Wang, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-26567-2 · Cited by 50
Mooi, C. S. (2018) · Primary Health Care Open Access · doi:10.4172/2167-1079-c5-028 · Cited by 46
Benhalima, K., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., Block, C. E. M. D., et al. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100351 · Cited by 49
Cord Blood Metabolomics: Association With Newborn Anthropometrics and C-Peptide Across Ancestries
Kadakia, R., Talbot, O., Kuang, A., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Ilkayeva, O., Lowe, L. P., Metzger, B. E., Newgard, C. B., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00238 · Cited by 50
Freebairn, L., Occhipinti, J., Osgood, N. D., Kelly, P., McDonnell, G., & Rychetnik, L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218875 · Cited by 50
A role for placental kisspeptin in β cell adaptation to pregnancy
Bowe, J. E., Hill, T. G., Hunt, K. F., Smith, L. I. F., Simpson, S., Amiel, S. A., & Jones, P. M. (2019) · JCI Insight · doi:10.1172/jci.insight.124540 · Cited by 50
Zhong, L., Long, Y., Wang, S., Lian, R., Deng, L., Ye, Z., Wang, Z., & Liu, B. (2020) · Placenta · doi:10.1016/j.placenta.2020.02.004 · Cited by 50
Hajimoosayi, F., Sadatmahalleh, S. J., Kazemnejad, A., & Pirjani, R. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-02908-5 · Cited by 54
Gao, Q. F., Zhong, C., Zhou, X., Chen, R., Xiong, T., Hong, M., Li, Q., Kong, M., Xiong, G., Han, W., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.05.053 · Cited by 49
Yang, J., Wang, H., Du, H., Xu, L., Liu, S., Yi, J., Chen, Y., Jiang, Q., & He, G. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-11263-4 · Cited by 46
Gestational Diabetes During and After Pregnancy
Kim, C., & Ferrara, A. M. (2010) · Springer eBooks · doi:10.1007/978-1-84882-120-0 · Cited by 56
Noventa, M., Vitagliano, A., Quaranta, M., Borgato, S., Abdulrahim, B., & Gizzo, S. (2015) · Reproductive Sciences · doi:10.1177/1933719115594018 · Cited by 49
Maitland, R., Seed, P. T., Briley, A. L., Homsy, M., Sanders, T. A. B., Pasupathy, D., Robson, S. C., Nelson, S. M., Sattar, N. A., & Poston, L. (2014) · Diabetic Medicine · doi:10.1111/dme.12482 · Cited by 49
Glucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria
Benhalima, K., Jegers, K., Devlieger, R., Verhaeghe, J., & Mathieu, C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0157272 · Cited by 45
Diagnosis of gestational diabetes mellitus: it is time for international consensus
Sacks, D. B. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.206920 · Cited by 45
Sleep quality and gestational diabetes in pregnant women: a systematic review and meta-analysis
Zhu, B., Shi, C., Park, C. G., & Reutrakul, S. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2019.11.1246 · Cited by 45
Gestational Diabetes Mellitus in Southeast Asia: A Scoping Review
Kunasegaran, T., Balasubramaniam, V. R. M. T., Arasoo, V. J. T., Palanisamy, U. D., & Ramadas, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031272 · Cited by 45
“Furthermore, the long-term significance of a diagnosis of GDM using the CC/NDGG/WHO/IADPSG/ADA criteria in predicting the future risk of T2DM and other maternal and fetal outcomes among Southeast Asian women was not extensively studied.”
BackgroundInfluentialMaternal Glycemia During Pregnancy and Early Offspring Development: A Prospective Birth Cohort Study
Wang, P., Xie, J., Jiao, X. C., Ma, S., Liu, Y., Yin, W., Tao, R., Hu, H., Zhang, Y., Chen, X., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab331 · Cited by 46
Pintaudi, B., Di Vieste, G., Corrado, F., Lucisano, G., Pellegrini, F., Giunta, L., Nicolucci, A., D'Anna, R., & Di Benedetto, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0759 · Cited by 44
Does gestational diabetes affect fetal growth and pregnancy outcome in twin pregnancies?
Tward, C., Barrett, J. F. R., Berger, H. M., Kibel, M., Pittini, A., Halperin, I. J., Cohen, H. R., & Melamed, N. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.11.006 · Cited by 46
Modifiable risk factors for gestational diabetes recurrence
Schwartz, N., Green, M. S., Yefet, E., & Nachum, Z. (2016) · Endocrine · doi:10.1007/s12020-016-1087-2 · Cited by 50
“It’s a Very Big Burden on Me”: Women’s Experiences Using Insulin for Gestational Diabetes
Gray, M. F., Hsu, C. W., Kiel, L. M., & Dublin, S. (2017) · Maternal and Child Health Journal · doi:10.1007/s10995-017-2261-8 · Cited by 51
Yasuhi, I., Soda, T., Yamashita, H., Urakawa, A., Izumi, M., Kugishima, Y., & Umezaki, Y. (2017) · International Breastfeeding Journal · doi:10.1186/s13006-017-0123-z · Cited by 43
Impact of risk factors for gestational diabetes (GDM) on pregnancy outcomes in women with GDM
Filardi, T., Tavaglione, F., Stasio, M. D., Fazio, V. M., Lenzi, A., & Morano, S. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0791-y · Cited by 51
Gestational diabetes mellitus modulates cholesterol homeostasis in human fetoplacental endothelium
Sun, Y., Kopp, S., Strutz, J., Gali, C. C., Zandl‐Lang, M., Fanaee‐Danesh, E., Kirsch, A., Cvitic, S., Frank, S., Saffery, R., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.05.005 · Cited by 50
Henriksson, P., Sandborg, J., Blomberg, M. I., Alexandrou, C., Maddison, R., Silfvernagel, K., Henriksson, H., Leppänen, M. H., Migueles, J. H., Widman, L., et al. (2019) · JMIR Research Protocols · doi:10.2196/13011 · Cited by 48
Falcone, V., Kotzaeridi, G., Breil, M. H., Rosicky, I., Stopp, T., Yerlikaya-Schatten, G., Feichtinger, M., Eppel, W., Husslein, P., Tura, A., et al. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0218 · Cited by 42
First Trimester Combined Test (FTCT) as a Predictor of Gestational Diabetes Mellitus
Visconti, F., Quaresima, P., Chiefari, E., Caroleo, P., Arcidiacono, B., Puccio, L., Mirabelli, M., Foti, D. P., Di Carlo, C., Vero, R., et al. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16193654 · Cited by 44
Kapustin, R. V., Дробинцева, А. О., Alekseenkova, E. N., Onopriychuk, A. R., Arzhanova, O. N., Polyakova, V. O., & Kvetnoy, I. M. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-019-05408-1 · Cited by 50
“5 mmol/l (153 mg/dl) [14], and PE according to the definition of the International Society for the Study of Hypertension in Pregnancy (ISSHP) [15].”
MethodAntoniou, M.-C., Gilbert, L., Gross, J., Rossel, J., Fumeaux, C. J. F., Vial, Y., & Puder, J. J. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2610-2 · Cited by 46
Edelson, P. K., James, K. E., Leong, A., Arenas, J., CAYFORD, M., Callahan, M. J., Bernstein, S. N., Tangren, J. S., Hivert, M., Higgins, J. M., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa053 · Cited by 55
Serum miR‐195‐5p is upregulated in gestational diabetes mellitus
Wang, J., Pan, Y., Dai, F., Wang, F., Qiu, H., & Huang, X. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23325 · Cited by 48
Mustafa, M., Bogdanet, D., Khattak, A., Carmody, L. A., Kirwan, B., Gaffney, G., O’Shea, P. M., & Dunne, F. (2020) · QJM · doi:10.1093/qjmed/hcaa167 · Cited by 51
Zhang, Z., Wu, Y., Zhong, C., Zhou, X., Liu, C., Li, Q., Chen, R., Gao, Q. F., Li, X., Zhang, H., et al. (2021) · Nutrition · doi:10.1016/j.nut.2021.111193 · Cited by 50
Zhao, Y. M., Zhao, Y., Fan, K., & Jin, L. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101293 · Cited by 50
Zhu, Y., Barupal, D. K., Ngo, A. L., Quesenberry, C. P., Feng, J., Fiehn, O., & Ferrara, A. M. (2022) · Diabetes · doi:10.2337/db21-1093 · Cited by 50
Wilmot, E. G., & Mansell, P. (2014) · Clinical Medicine · doi:10.7861/clinmedicine.14-6-677 · Cited by 48
Abouzeid, M., Versace, V. L., Janus, E. D., Davey, M.-A., Philpot, B., Oats, J., & Dunbar, J. A. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005394 · Cited by 45
A Review of Research Progress on Glycemic Variability and Gestational Diabetes
Yu, W., Wu, N., Li, L., OuYang, H., Qian, M., & Shen, H. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s261486 · Cited by 44
Dittkrist, L., Vetterlein, J., Henrich, W., Ramsauer, B., Schlembach, D., Abou‐Dakn, M., Gembruch, U., Schild, R. L., Duewal, A., & Schaefer-Graf, U. M. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04519-z · Cited by 44
“GDM was diagnosed by a 75 g oral glucose tolerance test performed at 24–27 gestational weeks using the International Association of DM and Pregnancy Study Groups criteria [6].”
MethodZgutka, K., Tkacz, M., Tomasiak, P., Piotrowska, K., Ustianowski, P., Pawlik, A., & Tarnowski, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111409 · Cited by 50
Tieu, J., Shepherd, E. S., Middleton, P., & Crowther, C. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010211.pub3 · Cited by 49
DNA Damage and Its Cellular Response in Mother and Fetus Exposed to Hyperglycemic Environment
Moreli, J. B., Santos, J. H., Rocha, C. R. R., Damasceno, D. C., Morceli, G., Rudge, M. V. C., Bevilacqua, E. M. A. F., & Calderon, I. D. M. P. (2014) · BioMed Research International · doi:10.1155/2014/676758 · Cited by 46
Bonis, C., Lorenzini, F., Bertrand, M., Parant, O., Gourdy, P., Vaurs, C., Cazals, L., Ritz, P., & Hanaire, H. P. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2061-z · Cited by 48
The prevalence of hyperglycaemia in pregnancy in Australia
Moses, R. G., Wong, V. C. K., Lambert, K., Morris, G. J., & San Gil, F. (2016) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12447 · Cited by 41
Genetic origins of low birth weight
Yaghootkar, H., & Freathy, R. M. (2012) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328351f543 · Cited by 44
Tripathi, R., Verma, D., Gupta, V. K., Tyagi, S., Kalaivani, M., Ramji, S., & Mala, Y. (2017) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1716_15 · Cited by 53
Mak, J. K. L., Pham, N. M., Lee, A. H., Tang, L., Pan, X., Binns, C. W., & Sun, X. (2018) · Nutrition Journal · doi:10.1186/s12937-018-0413-3 · Cited by 48
“GDM cases were confirmed using the IADPSG diagnostic criteria [35], including at least one of the following values being met: fasting serum glucose ≥5.”
MethodLI, P., Lin, S., Li, L., Cui, J., Zhou, S., & Fan, J. (2019) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.35.1.216 · Cited by 43
Herath, R. P., Siriwardana, S. R., Ekanayake, C. D., Abeysekara, V., Kodithuwakku, S. U. A., & Herath, H. P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215326 · Cited by 49
Zhang, Q.-Q., Li, X., Liu, X., Dong, M., Xiao, J., Wang, J., Zhou, M., Wang, Y., Ning, D., Ma, W., et al. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.125732 · Cited by 45
Crusell, M. K. W., Brink, L. R., Nielsen, T., Allin, K. H., Hansen, T. F., Damm, P., Lauenborg, J., Hansen, T. H., & Pedersen, O. B. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-2764-y · Cited by 49
Thayer, S. M., Lo, J. O.-T., & Caughey, A. B. (2020) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2020.04.002 · Cited by 51
Wysham, C., & Kirkman, M. S. (2011) · Diabetes Care · doi:10.2337/dc11-0262 · Cited by 49
Song, T., Su, G., Chi, Y., Wu, T., Xu, Y., & Chen, C. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1940932 · Cited by 46
“The International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria was applied for the diagnosis of GDM in four studies [19–22], which generally used criteria and involved a 2 h 75-g OGTT after 8–10 h fasting between 24 and 28 weeks of gestation; and GDM is diagnosed when one or more values meet th…”
MethodWang, W., Zhao, Y., Zhou, X., Sung, N., Chen, L., Zhang, X., Ma, D., Zhu, P., & Kwak-Kim, J. Y.-H. (2022) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2022.103492 · Cited by 44
Song, X., Shu, J., Zhang, S., Chen, L., Diao, J., Li, J., Li, Y., Wei, J., Liu, Y., Sun, M., et al. (2022) · Nutrients · doi:10.3390/nu14051072 · Cited by 49
Gao, Y., Chen, H., Li, J., Ren, S., Yang, Z., Zhou, Y., & Xuan, R. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24333 · Cited by 45
Thériault, S., Forest, J., Massé, J., & Giguère, Y. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.009 · Cited by 48
“[2 4 ] n = 5 3 0 2 2 8 0 G D M 1 9 5 In s 6 0 .”
BackgroundMethodInfluentialBenhalima, K., Van Crombrugge, P., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Dufraimont, E., De Block, C., Jacquemyn, Y., Mekahli, F., et al. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-226 · Cited by 43
Assessment of glucose regulation in pregnancy after gastric bypass surgery
Göbl, C. S., Bozkurt, L., Tura, A., Leutner, M., Andrei, L., Fahr, L., Husslein, P. W., Eppel, W., & Kautzky‐Willer, A. (2017) · Diabetologia · doi:10.1007/s00125-017-4437-6 · Cited by 46
Metadata
- Authors
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Corresponding author
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-03-01
- Volume
- 33
- Issue
- 3
- Pages
- 676-682
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2827530
- OpenAlex
- W2616235706
- Cited by
- 5,390
- References
- 56
- Citations by year
- 2026: 314 · 2025: 377 · 2024: 446 · 2023: 423 · 2022: 494 · 2021: 507 · 2020: 425 · 2019: 350 · 2018: 367 · 2017: 297 · 2016: 274 · 2015: 296 · 2014: 235 · 2013: 203 · 2012: 167
- FWCI
- 250.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- American Diabetes Association
- Kaiser Permanente
- National Institute of Child Health and Human Development (R01‐HD34242, R01-HD-34243)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD-34243, R01-HD-34242, R01HD034242, R01HD034243)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- gestational diabetes mellitus, hyperglycemia in pregnancy, IADPSG criteria, perinatal outcomes, maternal glycemia, diagnostic thresholds
- MeSH terms
- Female, Health Planning Guidelines, Humans, Hyperglycemia, International Cooperation, Pregnancy, Pregnancy Complications, Pregnancy in Diabetics, Societies, Medical, Diabetes, Gestational, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.